TERVEYSTALO PLC STOCK EXCHANGE RELEASE October 17, 2017 at 2:30 p.m.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Terveystalo Plc's ten largest shareholders after the completion of the Initial Public Offering
The ten largest registered shareholders of Terveystalo Plc ("Terveystalo" or the "Company") and their shares of ownership after the Initial Public Offering (the "Offering") are shown in the table below. Shareholders' holdings have been retrieved from the shareholders' register maintained by Euroclear Finland Ltd (situation as at October 16, 2017).
| Shareholder | Number of shares | % of shares and votes |
| 1. Varma Mutual Pension Insurance Company | 19,223,816 | 15.0 |
| 2. Lotta Holding I S.à r.l. | 14,510,320 | 11.3 |
| 3. Helsinki Deaconess Institute Foundation sr | 13,470,705 | 10.5 |
| 4. Hartwall Capital | 12,931,690 | 10.1 |
| 5. Rettig Group AB | 12,931,690 | 10.1 |
| 6. Ilmarinen Mutual Pension Insurance Company | 6,450,000 | 5.0 |
| 7. Elo Mutual Pension Insurance Company | 5,122,951 | 4.0 |
| 8. Mandatum Life Unit-Linked | 1,238,351 | 1.0 |
| 9. Odco Oy | 1,225,000 | 1.0 |
| 10. OP-Suomi -sijoitusrahasto | 1,090,000 | 0.9 |
| Ten largest(1), in total | 88,194,523 | 68.9 |
| Other shareholders | 39,842,008 | 31.1 |
| of which nominee-registered shares | 20,876,188 | 16.3 |
| Total | 128,036,531 | 100.0 |
| (1) Terveystalo's CEO Yrjö Närhinen holds in total 1,316,459 shares, consisting of 556,353 shares owned by Närhen pesä Oy, which he controls, and 760,106 shares held by Mandatum Life Insurance Company Limited, Mr. Närhinen being the ultimate beneficiary. | ||
The following table sets forth for illustrative purposes the ten largest shareholders of Terveystalo before the execution of the Offering but after the Company's share class combination and issuance of new shares without payment in proportion to shareholdings (share split) completed on October 10, 2017, as well as taking into account the review of shareholdings to correspond to the principles of the share class combination contained in the Articles of Association effective until October 10, 2017, as agreed between shareholders.
| Shareholder | Number of shares | % of shares and votes |
| 1. Lotta Holding I S.à r.l. | 90,832,836 | 77.1 |
| 2. Helsinki Deaconess Institute Foundation sr | 14,967,450 | 12.7 |
| 3. Varma Mutual Pension Insurance Company | 4,755,687 | 4.0 |
| 4. Yrjö Närhinen(1) | 1,316,459 | 1.1 |
| 5. Juha Tuominen(2) | 556,353 | 0.5 |
| 6. Ilkka Laurila | 308,923 | 0.3 |
| 7. Fredrik Cappelen(3) | 267,795 | 0.2 |
| 8. Olli Jurvainen | 134,370 | 0.1 |
| 9. Kari Kangasniemi | 134,370 | 0.1 |
| 10. Juha-Pekka Lyytikkä | 134,370 | 0.1 |
| Ten largest, in total | 113,408,613 | 96.3 |
| Other shareholders | 4,346,669 | 3.7 |
| Total | 117,755,282 | 100.0 |
| (1) Yrjö Närhinen's ownership consisted of 556,353 shares owned by Närhen pesä Oy, which he controls, and 760,106 shares held by Mandatum Life Insurance Company Limited, Mr. Närhinen being the ultimate beneficiary. | ||
| (2) Juha Tuominen's ownership consisted of 556,353 shares held by Mandatum Life Insurance Company Limited, Mr. Tuominen being the ultimate beneficiary. | ||
| (3) Fredrik Cappelen's ownership consisted of 267,795 shares owned by Baskina AB, which he controls. | ||
Terveystalo Plc
Communications
Further enquiries
Yrjö Närhinen, CEO, Terveystalo
yrjo.narhinen@terveystalo.com
Susanna Kinnari, SVP Communications, Marketing and Brand, Terveystalo
Tel. +358 (50) 5458333
susanna.kinnari@terveystalo.com
Kati Kaksonen, Director, Investor Relations & Finance Communications, Terveystalo
Tel. +358 (50) 3931561
kati.kaksonen@terveystalo.com
Distribution:
Nasdaq Helsinki Ltd
Principal media
www.terveystalo.com
Terveystalo in brief
Terveystalo is a leading private healthcare service provider in Finland offering primary and outpatient secondary healthcare services to corporate, private and public sector customers. The Company's healthcare service offering includes general practice and specialist medical care, diagnostic services, outpatient surgery, dental services and other adjacent services, which comprise its integrated healthcare care chain. The Company also offers a suite of digital healthcare services. Terveystalo is able to provide nationwide reach through its approximately 180 clinics, covering all 20 of Finland's largest cities, together with its digital platforms.
Terveystalo's operations are driven by its scale and supported by centralized functions and standardized operating practices. At the core of Terveystalo's strategy is a focus on providing medical quality and positive customer experiences, maintaining a competent and satisfied base of healthcare professionals and developing a variety of customized digital tools.
In 2016, the Company had approximately 1.0 million individual customers as well as approximately 2.7 million doctor visits, accounting for 12 percent of the total doctor visits in Finland. The Company's customers are divided into three groups: corporate customers, who the Company partners with to provide, for example, occupational healthcare services to their employees, private customers and public customers, who the Company partners with to provide public healthcare services and occupational healthcare services to municipal employees. Terveystalo had approximately 4,445 employees (including part-time employees) and approximately 4,400 private practitioners as at June 30, 2017.
DISCLAIMER
This announcement does not constitute an offer for sale of, or a solicitation of an offer to purchase or subscribe for, any securities in the United States. Securities may not be offered or sold in the United States unless they are registered or are exempt from registration under the U.S. Securities Act of 1933, as amended. The information contained in this announcement is for informational purposes only and does not purport to be full or complete. Terveystalo does not intend to register any offering in the United States or to conduct a public offering in the United States. Copies of this announcement are not being, and should not be, distributed in or sent into the United States.
It may be unlawful to distribute this announcement in certain jurisdictions. This announcement is not for distribution in Australia, Canada, the Hong Kong special administrative region of the People's Republic of China, Japan, South Africa, the United States or to any other jurisdiction where such distribution would be unlawful. The information in this announcement does not constitute an offer of securities for sale in such jurisdictions.
In the United Kingdom, this announcement is for distribution only to and is directed only at persons who (i) have professional experience in matters relating to investments which fall within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Financial Promotion Order"), (ii) are persons falling within Article 49(2)(a) to (d) ("high net worth companies, unincorporated associations etc.") of the Financial Promotion Order, or (iii) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "Relevant Persons"). This announcement is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons.
This announcement has been prepared on the basis that any offer of securities in any Member State of the European Economic Area, other than Finland and Sweden, which has implemented the Prospectus Directive (2003/71/EC, as amended, including by Directive 2010/73/EU, the "Prospectus Directive") (each, a "Relevant Member State") is made pursuant to an exemption under the Prospectus Directive, as implemented in that Relevant Member State, from the requirement to publish a prospectus for offers of securities. Accordingly the securities may only be offered in Relevant Member States (a) to any legal entity which is a qualified investor as defined in the Prospectus Directive; or (b) in any other circumstances falling within Article 3(2) of the Prospectus Directive.
This announcement does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any shares or any other securities nor shall it (or any part of it) or the fact of its distribution, form the basis of, or be relied on in connection with, any contract therefor. The information in this announcement is subject to change.